[Research on Stability Evaluation Method for Key Performance of Clinical Mass Spectrometer Based on SPC]
Jiansong Xia1, Ruobiao Li2, Guofei Yan1
1Zhejiang Center for Medical Device Evaluation, Hangzhou, 310009.
Abstract:
As a Class Ⅱ medical device, clinical mass spectrometers face challenges in performance stability when operating in long-term, high-volume, and high-matrix clinical application scenarios. However, a unified standard method for evaluating performance stability has not yet been established domestically or internationally. This study aims to construct a scientific and universal evaluation system for the key performance stability of clinical mass spectrometers based on the statistical process control (SPC) theory, providing technical support for the access review of regulatory authorities and the quality improvement of manufacturing enterprises. Firstly, based on the division of clinical application needs and risk levels, key performance parameters such as detection limit and anti-interference capability, as well as their importance levels, are determined. Secondly, key performance data are collected by simulating actual clinical operating scenarios, and the X-bar-R control chart is used to judge the statistical steady state. Subsequently, the stability capability index (SCI) is developed with the process performance index (PP) as the core for technical steady-state evaluation. Finally, the stability levels are classified through the combined determination of statistical steady state and technical steady state. The effectiveness of the method is verified through the detection limit test using ICP-MS. The results show that this method can not only effectively evaluate the key performance stability of the instrument but also identify the root causes of instrument performance fluctuations. The conclusion indicates that the SPC-based method for evaluating the key performance stability of clinical mass spectrometers is scientific, operable, and economical. It can not only accurately predict the performance degradation trend of instruments and warn of failure risks but also provide a unified standard for the whole-life cycle quality control of medical devices. It is applicable to the stability evaluation of different types of clinical mass spectrometers and is of great significance for standardizing industry quality standards and improving clinical application safety.
More Related Videos
09:43Subtyping of Campylobacter jejuni ssp. doylei Isolates Using Mass Spectrometry-based PhyloProteomics (MSPP)
Published on: October 30, 2016
11:00Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry (UPLC-HRMS)
Published on: May 20, 2013
Related Concept Videos
Mass Spectrometry: Overview
Tandem Mass Spectrometry
Mass Spectrometry: Complex Analysis
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
Mass Spectrometers
Mass Analyzers: Overview
MALDI-TOF Mass Spectrometry
